Carnitine Palmitoyltransferase 2 (CPT2) (N-Term) Peptide
CPT2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511804
Quick Overview for Carnitine Palmitoyltransferase 2 (CPT2) (N-Term) Peptide (ABIN5511804)
Target
CPT2
(Carnitine Palmitoyltransferase 2 (CPT2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- FNPFMAFNPD PKSEYNDQLT RATNMTVSAI RFLKTLRAGL LEPEVFHLNP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CPT2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CPT2 (Carnitine Palmitoyltransferase 2 (CPT2))
-
Background
-
The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
Alias Symbols: CPT2,CPT1,
Protein Size: 658 -
Gene ID
- 1376
-
NCBI Accession
- NP_000089
-
UniProt
- P23786
Target
-
You are here:
